{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:27:51Z","timestamp":1772000871192,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Orbital Apex Syndrome (OAS) is a disease of multiple brain nerves at the orbital apex leading to vision loss and neurological impairments. Diabetes Mellitus (DM), a metabolic disorder with cardiovascular, immunological and neurological effects, is involved in OAS pathogenesis. However, the association between DM and OAS is not well studied. DM and OAS are poorly understood and may not be diagnosed correctly, especially when outbreaks such as COVID-19 are being investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of 33 studies published between 2000 and 2025 was conducted to analyze DM-related OAS epidemiology, pathophysiology, clinical phenotypes, and treatment outcomes, focusing on the mechanistic links, pandemic trends, and glycemic control effect on therapeutic effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Chronic hyperglycemia induced orbital apex microvascular damage (endothelial dysfunction, thrombosis, vascular senescence), immunosuppression induced opportunistic infections (mostly mucormycosis), and diabetic neuropathy induced neuromuscular dysfunction. During COVID-19, diabetic patients had the highest OAS incidence (more than 70% of cases involved rhino-orbital mucormycosis). Optimal glycemic control is associated with a 32% higher antifungal treatment effectiveness and a 28% lower rate of surgical complications. Epidemiological data showed that DM was the main predisposing factor, with 71.4%\u201381.8% infectious OAS cases occurred in diabetic populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DM is underreported as a critical catalyst for OAS with complications directly increasing severity and progression. Routine DM screening (e.g., glycated hemoglobin monitoring) and integrated glycemic management are essential for OAS prevention and treatment. Long-term studies on inflammatory factors and personalized multidisciplinary care are needed to address mechanistic gaps and improve visual and neurological outcomes in high-risk diabetic patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1770045","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:34:07Z","timestamp":1771997647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the hidden link: diabetes mellitus as a catalyst for orbital apex syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Shu Xin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/EB.S180190","article-title":"Orbital apex syndrome: A review","volume":"11","author":"Badakere","year":"2019","journal-title":"Eye Brain"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/jpn.JPN_114_20","article-title":"Orbital apex syndrome: A clinico-anatomical diagnosis","volume":"15","author":"Saini","year":"2020","journal-title":"J Pediatr Neurosci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"115723","DOI":"10.1016\/j.bcp.2023.115723","article-title":"Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies","volume":"215","author":"Kaur","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12886-016-0189-1","article-title":"A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially","volume":"16","author":"Jiang","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2024.05.17","article-title":"Prognostic factors and clinical features of rhino-orbital-mucormycosis cases: an update for patient and visual survivals","volume":"17","author":"Aksoy","year":"2024","journal-title":"Int J Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4812","article-title":"Gene therapy for autoimmune disease","volume":"95","author":"Fathman","year":"2000","journal-title":"Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-010-0008-3","article-title":"The options to minimize the surgical trauma to treat ocular diabetic complications and to improve postoperative recovery and quality of life require an individualized approach","volume":"1","author":"Schrader","year":"2010","journal-title":"EPMA J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12278","article-title":"Evaluation of 28 cases of mucormycosis","volume":"58","author":"Kursun","year":"2015","journal-title":"Mycoses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin23.454","article-title":"Clinical characteristics and management of orbital apex syndrome: a 10-year multicentre experience","volume":"62","author":"Im","year":"2024","journal-title":"Rhinology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-021-00845-5","article-title":"Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations","volume":"65","author":"Bayram","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S324977","article-title":"Rhino-orbito-cerebral-mucormycosis during the COVID-19 second wave in 2021-A preliminary report from a single hospital","volume":"15","author":"Arora","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0733-3","article-title":"Orbital mycoses in an adult subtropical population","volume":"34","author":"Lee","year":"2020","journal-title":"Eye (Lond)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-019-01774-z","article-title":"Rhino-orbital-cerebral mucormycosis: battle with the deadly enemy","volume":"72","author":"Gupta","year":"2020","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"104601","DOI":"10.1016\/j.phrs.2019.104601","article-title":"The pivotal role of nuclear factor erythroid 2-related factor 2 in diabetes-induced endothelial dysfunction","volume":"153","author":"Karan","year":"2020","journal-title":"Pharmacol Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"106143","DOI":"10.1016\/j.phrs.2022.106143","article-title":"NLRP3 inflammasome links vascular senescence to diabetic vascular lesions","volume":"178","author":"Tai","year":"2022","journal-title":"Pharmacol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12879-017-2753-6","article-title":"Orbital apex syndrome secondary to a fungal nasal septal abscess caused by Scedosporium apiospermum in a patient with uncontrolled diabetes: a case report","volume":"17","author":"Kishimoto","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13231","DOI":"10.1111\/obr.13231","article-title":"The role of autoimmunity in the pathophysiology of type 2 diabetes: Looking at the other side of the moon","volume":"22","author":"Koufakis","year":"2021","journal-title":"Obes Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.21506","article-title":"Orbital apex syndrome affecting head and neck cancer patients: A case series","volume":"22","author":"Prado-Ribeiro","year":"2017","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2020.06.046","article-title":"Impaired pupillary light reflex indices in Orbital Apex Syndrome-A rare case report","volume":"44","author":"Siva Kumar","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S83036","article-title":"Acute orbital apex syndrome and rhino-orbito-cerebral mucormycosis","volume":"8","author":"Anders","year":"2015","journal-title":"Int Med Case Rep J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.JNMS.2019_86-409","article-title":"Central diabetes insipidus associated with orbital apex syndrome","volume":"86","author":"Yoon","year":"2019","journal-title":"J Nippon Med Sch"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omu045","article-title":"An unexpected cause of orbital apex syndrome in an immune-competent elderly male","volume":"2014","author":"Singh","year":"2014","journal-title":"Oxf Med Case Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12879-025-10439-y","article-title":"Use of isavuconazole in mucormycosis: a systematic review","volume":"25","author":"Gunathilaka","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: A clinical perspective","volume":"75","author":"Lamoth","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12281-023-00463-3","article-title":"Novel approaches in the management of mucormycosis","volume":"17","author":"Lamoth","year":"2023","journal-title":"Curr Fungal Infect Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.13201\/j.issn.2096-7993.2024.08.014","article-title":"Analysis of curative effect of orbital apex syndrome caused by sinus disease","volume":"38","author":"Dai","year":"2024","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00810","article-title":"Active moderate-to-severe graves\u2019 Orbitopathy in a patient with type 2 diabetes mellitus and vascular complications","volume":"9","author":"Urselli","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1906913","article-title":"Severe cocaine-induced midline destructive lesions (CIMDL) leading to orbital apex syndrome and peripheral ulcerative keratitis","volume":"30","author":"Ortiz-Seller","year":"2022","journal-title":"Ocul Immunol Inflammation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1120672120954042","article-title":"A systematic review of orbital apex syndrome of odontogenic origin: Proposed algorithm for treatment","volume":"31","author":"Leferman","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000538539","article-title":"Survival from rhino-orbital-cerebral mucormycosis in SARS-coV-2-positive diabetic patients: two case reports","volume":"16","author":"L\u00e4drach","year":"2024","journal-title":"Case Rep Neurol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-025-00973-5","article-title":"Gene therapy strategies in ophthalmology-an overview of current developments and future prospects","author":"Krajewska","year":"2025","journal-title":"J Appl Genet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tibtech.2019.12.021","article-title":"Enabling technologies for personalized and precision medicine","volume":"38","author":"Ho","year":"2020","journal-title":"Trends Biotechnol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1770045\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:34:08Z","timestamp":1771997648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1770045\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":33,"alternative-id":["10.3389\/fendo.2026.1770045"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1770045","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"1770045"}}